کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3854325 1598546 2013 16 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Hong Kong Renal Registry Report 2012
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی بیماری‌های کلیوی
پیش نمایش صفحه اول مقاله
Hong Kong Renal Registry Report 2012
چکیده انگلیسی

SummaryThis report examined the characteristics and trends of dialysis and renal transplant patients among the resident population of Hong Kong who were managed by hospitals or dialysis centers of the Hospital Authority, and accounted for approximately 95% of all patients receiving renal replacement therapies (RRTs) in the territory. Patients receiving RRTs solely in the private sector were not included in this report. Data trends from 1996 to 2011 are presented. In 2011, 1115 new patients were accepted into RRT programs, and the incident rate was 157 patients per million populations (pmp). An increasing trend was noted. The incident rate was 95.1 pmp at the commencement of the annual report in 1996. The point prevalence on December 31, 2012 was 8197 with a prevalence rate of 1152.5 pmp. Overall, there were 3573 patients (43.6%) on peritoneal dialysis (PD) and 1246 patients (15.2%) on hemodialysis (HD), and 3378 patients (41.2%) were living with a functioning renal transplant. The PD/HD ratio was 74.2:25.8. The “PD First” policy was continued. The overall mortality rate among RRT patients was 9.95 patients per 100 patient-years exposed. There was a decreasing trend in mortality among PD patients. Infection and cardiovascular complications were the most common causes of death. Renal transplant was the modality with the best survival rates. The 5 years cumulative patient survival rate for patients on transplant treatment was 89.6%, whereas the corresponding patient survival rates for PD and HD patients were 50.7% and 55.7%, respectively. More than 70% of RRT patients with reports on rehabilitation were active and had normal daily activities.

本報告旨在審查在香港地區之透析及腎臟移植患者的狀況,這些患者均是香港居民,接受香港醫院管理局轄下的醫院或透析中心所提供的治療,約佔當地腎臟替代療法 (RRT) 總病人數目的九成半,僅在私營醫院接受 RRT 的患者並不包括在本報告之內。以下是 1996 年至 2011 年的數據趨勢。在 2011 年,共有 1115 名新患者被納入 RRT 服務計劃,發生率為每百萬人口 157 人 (pmp),比較在 1996 年的年度報告中發生率為 95.1 PMP,有增加的趨勢。截至2012年 12 月 31 日,點盛行個案為 8197,而患病率為 1152.5 pmp。當中有 3573 患者接受腹膜透析 (PD,43.6%),1246 患者接受血液透析 (HD,15.2%),以及 3378 名患者接受腎臟移植後繼續存活 (41.2%)。PD 與 HD比例為 74.2:25.8,持續了優先採用腹膜透析治療之政策。RRT 患者的整體死亡率為每 100 患者-年 9.95 人。PD 患者的死亡率呈下降趨勢。感染和心血管併發症是最常見的死亡原因。接受腎移植患者的存活率為最高,5年累計之存活率達 89.6%,相對 PD 和 HD 患者之存活率分別為 50.7% 和 55.7%。超過七成的 RRT 患者能維持正常的日常生活。

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Hong Kong Journal of Nephrology - Volume 15, Issue 1, April 2013, Pages 28–43
نویسندگان
, , , , , , , , , , , ,